Aphthasol Articles
Mochida seeks OTC switch for Epadel
9 February 2009
Access and Discus Dental in amlexanox deal
25 April 2005
Approvals for Access' Aphthasol in Europe
7 March 2005
Access to reap the benefits of licensing deals
20 January 2003
Strakan launches home-grown acne drug Zindaclin in UK
25 March 2002
Access gets UK approval for Zindaclin
24 October 2001
UK approves Access' Aptheal
23 October 2001
Promising Ph II data for Access' OraRinse
25 July 2001
Recent developments in drug delivery - by Mark Greener
19 January 2000
Euro Licenses For Access' Amlexanox
8 October 1998
Strakan Submit Access's Amlexanox
20 August 1998
Strakan Licenses Amlexanox
30 July 1998
FDA Year-End Approval Spate As Expected
6 January 1997
Block's Apthasol Nears Approval
27 May 1996
Chemex And Block Disolve Agreement
27 March 1995
Showing 1-17 of 17 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
